{"entity":{"type":"insider","cik":"0001496194","url":"/insider/0001496194","json_url":"/insider/0001496194.json","name":"Naftzger J. Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2011-03-02","last":"2025-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Naftzger J. Christopher","source":"filing","n_filings":4,"first_seen":"2011-03-02","last_seen":"2025-02-05"}],"transactions":[{"id":5048149,"accession":"0001447028-25-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447028-25-000037","line_url":"/filing/0001447028-25-000037#line-1","is_derivative":false,"issuer_cik":"0001447028","issuer_name":"Arbutus Biopharma Corp","issuer_ticker":"ABUS","issuer_name_source":null,"issuer_url":"/issuer/0001447028","owner_cik":"0001496194","owner_name":"Naftzger J. Christopher","owner_display_name":"Naftzger J. Christopher","owner_url":"/insider/0001496194","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11333.0,"shares_display":"11,333","price_per_share":3.283,"price_display":"3.28","price_state":"stated","total_value":37206.239,"total_display":"37,206.24","total_whole":"37,206","shares_owned_after":86244.0,"shares_owned_after_display":"86,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-05","scope":"insider"},{"id":5248764,"accession":"0001104659-21-154012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-154012","line_url":"/filing/0001104659-21-154012#line-1","is_derivative":false,"issuer_cik":"0001496194","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001496194","owner_cik":"0001496194","owner_name":"Naftzger J. Christopher","owner_display_name":"Naftzger J. Christopher","owner_url":"/insider/0001496194","role":"Officer (General Counsel and Corp Sec)","role_mark":"O","role_mark_label":"Officer (General Counsel and Corp Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Corp Sec","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":4130.0,"total_display":"4,130.00","total_whole":"4,130","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-28","scope":"insider"},{"id":9104269,"accession":"0001209191-11-057710","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-057710","line_url":"/filing/0001209191-11-057710#line-1","is_derivative":false,"issuer_cik":"0001476170","issuer_name":"Unilife Corp","issuer_ticker":"UNIS","issuer_name_source":null,"issuer_url":"/issuer/0001476170","owner_cik":"0001496194","owner_name":"Naftzger J. Christopher","owner_display_name":"Naftzger J. Christopher","owner_url":"/insider/0001496194","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.9552,"price_display":"3.96","price_state":"stated","total_value":7910.4,"total_display":"7,910.40","total_whole":"7,910","shares_owned_after":41940.0,"shares_owned_after_display":"41,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-22","filed_date":"2011-11-22","scope":"insider"},{"id":9102975,"accession":"0001209191-11-014476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-014476","line_url":"/filing/0001209191-11-014476#line-1","is_derivative":false,"issuer_cik":"0001476170","issuer_name":"Unilife Corp","issuer_ticker":"UNIS","issuer_name_source":null,"issuer_url":"/issuer/0001476170","owner_cik":"0001496194","owner_name":"Naftzger J. Christopher","owner_display_name":"Naftzger J. Christopher","owner_url":"/insider/0001496194","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":14100.0,"total_display":"14,100.00","total_whole":"14,100","shares_owned_after":43000.0,"shares_owned_after_display":"43,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001447028","name":"Arbutus Biopharma Corp","url":"/issuer/0001447028","role":"Officer (General Counsel and CCO)","n_filings":1,"first_seen":"2025-02-05","last_seen":"2025-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Officer (General Counsel and Corp Sec)","n_filings":1,"first_seen":"2021-12-28","last_seen":"2021-12-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001476170","name":"Unilife Corp","url":"/issuer/0001476170","role":"Officer","n_filings":2,"first_seen":"2011-03-02","last_seen":"2011-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001496194","retrieved_at":"2026-08-23T23:17:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}